ArticleBMJ open gastroenterology2025

Effectiveness and safety of upadacitinib in a real-world cohort of patients with Crohn's disease in the UK: a multicentre retrospective cohort study.

Yaa Danso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.